Dr. David Mankoff, MD

• Nuclear Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Wash Affil Hosps

  Residency Hospital, 1992

• University Wash Affil Hosps

  Internship Hospital, 1991

• University Of Pennsylvania Perelman School Of Medicine

  Medical School, 1988

• Analysis of 4D data for total-body PET imaging, 2021-12-22

• Quantitation of Multiple Injection Dynamic PET Scans: An Investigation of the Benefits of Pooling Data from Separate Scans when Mapping Kinetics, 2021-07-01

• Imaging Cancer Metabolism: Underlying Biology and Emerging Strategies, 2018-09-01

• Effect of18F-FDG uptake time on lesion detectability in PET imaging of early stage breast cancer, 2016-01-12

• Principles of Tracer Kinetic Analysis in Oncology, Part II: Examples and Future Directions, 2022-04-01

• Correction to: Functional 4-D clustering for characterizing intratumor heterogeneity in dynamic imaging: evaluation in FDG PET as a prognostic biomarker for breast cancer, 2021-06-12

• Effect of18F-FDG Uptake Time on Lesion Detectability in PET Imaging of Early-Stage Breast Cancer, 2015-09-01

• Temporal Heterogeneity of Estrogen Receptor Expression in Bone-Dominant Breast Cancer:18F-Fluoroestradiol PET Imaging Shows Return of ER Expression, 2016-05-05

• The Impact of Positron Emission Tomography with18F-Fluciclovine on the Treatment of Biochemical Recurrence of Prostate Cancer: Results from the LOCATE Trial, 2020-01-16

• VOXEL-LEVEL MAPPING OF TRACER KINETICS IN PET STUDIES: A STATISTICAL APPROACH EMPHASIZING TISSUE LIFE TABLES, 2014-06-01

• A virtual clinical trial comparing static versus dynamic PET imaging in measuring response to breast cancer therapy, 2017-02-13

• Laboratory, Clinical, and Survival Outcomes Associated With Peptide Receptor Radionuclide Therapy in Patients With Gastroenteropancreatic Neuroendocrine Tumors Peptide Receptor Radionuclide Therapy Outcomes in Patients With Gastroenteropancreatic NETs, 2021-03-23

• The Value of Establishing the Quantitative Accuracy of PET/CT Imaging, 2015-06-18

• PREOPERATIVE MRI IMPROVES PREDICTION OF EXTENSIVE OCCULT AXILLARY LYMPH NODE METASTASES IN BREAST CANCER PATIENTS WITH A POSITIVE SENTINEL LYMPH NODE BIOPSY, 2014-09-19

• Letter to Cancer Center Directors: Progress in Quantitative Imaging As a Means to Predict and/or Measure Tumor Response in Cancer Therapy Trials, 2014-05-27

• Quantifying bias and precision of kinetic parameter estimation on the PennPET Explorer, a long axial field-of-view scanner, 2020-09-02

• Novel applications of molecular imaging to guide breast cancer therapy, 2022-06-21

• Effects of ranolazine on right ventricular function, fluid dynamics, and metabolism in patients with precapillary pulmonary hypertension: insights from a longitudinal, randomized, double-blinded, placebo controlled, multicenter study, 2023-06-13

• PennPET Explorer: Human Imaging on a Whole-Body Imager, 2020-01-01

• Multicenter clinical trials using18F-FDG PET to measure early oncology therapy response: Effects of injection-to-acquisition time variability on required sample size, 2015-10-22

• Radiopharmaceutical Chemistry and Drug Development-What's Changed?, 2020-07-30

• Castration-Resistant Prostate Cancer Bone Metastasis Response Measured by18F-Fluoride PET After Treatment with Dasatinib and Correlation with Progression-Free Survival: Results from American College of Radiology Imaging Network 6687, 2015-01-29

• Functional 4-D clustering for characterizing intratumor heterogeneity in dynamic imaging: evaluation in FDG PET as a prognostic biomarker for breast cancer, 2021-03-07

• A Phase 2 Study of 16a-[18F]-fluoro-17ß-estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC), 2013-10-30

• Quantitative Imaging in Cancer Clinical Trials, 2016-01-15

• The Use of Quantitative Imaging in Radiation Oncology: A Quantitative Imaging Network (QIN) Perspective, 2018-06-30

• [F-18]-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients using Image-derived Blood Surrogate Tissue Reference Regions, 2015-06-25

• Estrogen receptor binding (FES PET) and glycolytic activity (FDG PET) predict progression-free survival on endocrine therapy in patients with ER+ breast cancer, 2016-06-24

• Whole-Body [18F]-Fluoride PET SUV Imaging to Monitor Response to Dasatinib Therapy in Castration-Resistant Prostate Cancer Bone Metastases: Secondary Results from ACRIN 6687, 2021-04-25

• 18F-fluorodeoxyglucose (FDG) PET or18F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study, 2021-08-23

• The role of resting myocardial blood flow and myocardial blood flow reserve as a predictor of major adverse cardiovascular outcomes, 2020-02-13

• The contribution of physics to Nuclear Medicine: physicians' perspective on future directions, 2014-05-01